DocGo Inc. (NASDAQ:DCGO) Given Average Recommendation of “Hold” by Brokerages

Shares of DocGo Inc. (NASDAQ:DCGO) have received a consensus rating of “Hold” from the six analysts that are covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and three have issued a buy recommendation on the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $2.3750.

DCGO has been the subject of a number of research reports. Stifel Nicolaus decreased their price objective on DocGo from $4.00 to $2.50 and set a “buy” rating for the company in a report on Tuesday, March 17th. Weiss Ratings restated a “sell (e+)” rating on shares of DocGo in a research note on Thursday, June 18th. Canaccord Genuity Group decreased their price target on shares of DocGo from $1.50 to $1.00 and set a “hold” rating for the company in a research note on Wednesday, March 25th. Wall Street Zen raised shares of DocGo from a “sell” rating to a “hold” rating in a research note on Saturday, May 16th. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $3.00 price objective on shares of DocGo in a report on Tuesday, March 17th.

Institutional Investors Weigh In On DocGo

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. AQR Capital Management LLC lifted its position in DocGo by 219.1% during the 1st quarter. AQR Capital Management LLC now owns 476,645 shares of the company’s stock worth $1,258,000 after buying an additional 327,269 shares in the last quarter. Jane Street Group LLC grew its holdings in shares of DocGo by 18.8% in the 1st quarter. Jane Street Group LLC now owns 85,442 shares of the company’s stock valued at $226,000 after acquiring an additional 13,505 shares in the last quarter. Acadian Asset Management LLC bought a new position in shares of DocGo in the 1st quarter valued at about $338,000. Strs Ohio acquired a new stake in shares of DocGo in the first quarter valued at about $76,000. Finally, JPMorgan Chase & Co. increased its position in shares of DocGo by 16.8% in the second quarter. JPMorgan Chase & Co. now owns 290,354 shares of the company’s stock valued at $456,000 after acquiring an additional 41,679 shares during the last quarter. 56.44% of the stock is currently owned by institutional investors and hedge funds.

DocGo Stock Performance

DCGO stock opened at $0.60 on Monday. The stock has a 50-day moving average price of $0.58 and a two-hundred day moving average price of $0.68. DocGo has a 1 year low of $0.45 and a 1 year high of $1.78. The stock has a market cap of $58.95 million, a PE ratio of -0.31 and a beta of 1.02.

DocGo (NASDAQ:DCGO) last issued its quarterly earnings results on Monday, May 11th. The company reported ($0.12) EPS for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.10). The firm had revenue of $75.55 million during the quarter, compared to the consensus estimate of $72.48 million. DocGo had a negative net margin of 62.23% and a negative return on equity of 44.09%. On average, analysts forecast that DocGo will post -0.12 earnings per share for the current fiscal year.

About DocGo

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.